BRAF and colorectal carcinoma: Whereas we could not find any SARIFA-status ﻿dependent changes at a genetic level in our previous studies on CRC,14,17 which were based on small to moderate cohort sizes (n=45 and n=207), we now observed a significantly higher frequency of BRAF mutations within SARIFA-positive CRCs compared with SARIFA-negative CRCs.